ConductScience.org, home

Paper8995940

Long course and prognostic factors of virus-induced cirrhosis of the liver.

Gentilini P and 10 others. Am J Gastroenterol, 1997. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. Long course and prognostic factors of virus-induced cirrhosis of the liver. Papers, record 8995940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8995940

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long course and prognostic factors of virus-induced cirrhosis of the liver.
PubMed
Journal
Am J Gastroenterol
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
2.81
iCite
Revised in PubMed
2013-11-21
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gentilini PP
2Laffi GG
3La Villa GG
4Romanelli RGR G
5Buzzelli GG
6Casini-Raggi VV
7Melani LL
8Mazzanti RR
9Riccardi DD
10Pinzani MM
11Zignego ALA L

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis CMajor topic
Liver CirrhosisMajor topic
Bilirubin
Carcinoma, Hepatocellular
Chronic Disease
Esophageal and Gastric Varices
Female
Follow-Up Studies
Gastrointestinal Hemorrhage
Hepatic Encephalopathy
Humans
Jaundice
Liver Neoplasms
Male
Middle Aged
Prognosis
Retrospective Studies
Survival Rate

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
40929456COMPARING THE PREDICTIVE EFFICACY OF MELD AND ALBI SCORES IN LIVER CIRRHOSIS PATIENTS WITH ACUTE UPPER GASTROINTESTINAL BLEEDING.Arq Gastroenterol2025https://conductscience.org/library/papers/40929456PubMed
38947874Lobe-Based Hepatic Uptake Index of Gd-EOB-DTPA on Contrast-Enhanced MRI to Quantitatively Discriminate between Compensated and Decompensated Hepatitis B-Related Cirrhosis.Can J Gastroenterol Hepatol2024https://conductscience.org/library/papers/38947874PubMed
37538247Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.JHEP Rep2023https://conductscience.org/library/papers/37538247PubMed
36908849Emerging Therapeutic Targets for Portal Hypertension.Curr Hepatol Rep2023https://conductscience.org/library/papers/36908849PubMed
36498435The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile.Int J Environ Res Public Health2022https://conductscience.org/library/papers/36498435PubMed
32385703Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.Dig Dis Sci2021https://conductscience.org/library/papers/32385703PubMed
31936470Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany.Int J Environ Res Public Health2020https://conductscience.org/library/papers/31936470PubMed
31215410Epstein-Barr virus infection is associated with a higher Child-Pugh score and may predict poor prognoses for patients with liver cirrhosis.BMC Gastroenterol2019https://conductscience.org/library/papers/31215410PubMed
30622374Quality of life in patients with minimal hepatic encephalopathy.World J Gastroenterol2018https://conductscience.org/library/papers/30622374PubMed
30564001Current Diagnosis and Classification of Hepatic Encephalopathy.J Clin Exp Hepatol2018https://conductscience.org/library/papers/30564001PubMed
29507462The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies.Ann Gastroenterol2018https://conductscience.org/library/papers/29507462PubMed
29325277[Effect of Fuzheng Huayu capsules on survival rate of patients with liver cirrhosis].Zhonghua Gan Zang Bing Za Zhi2017https://conductscience.org/library/papers/29325277PubMed
27910116
The cost-effectiveness of testing for NS5a resistance-associated polymorphisms at baseline in genotype 1a-infected (treatment-naïve and treatment-experienced) subjects treated with all-oral elbasvir/grazoprevir regimens in the United States.
Aliment Pharmacol Ther2017https://conductscience.org/library/papers/27910116PubMed
26937441State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives.Eur J Radiol Open2015https://conductscience.org/library/papers/26937441PubMed
24616574Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis.World J Gastroenterol2014https://conductscience.org/library/papers/24616574PubMed
24057240Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma.Mol Biol Rep2013https://conductscience.org/library/papers/24057240PubMed
24041347Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.Value Health2013https://conductscience.org/library/papers/24041347PubMed
23621902Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.BMC Infect Dis2013https://conductscience.org/library/papers/23621902PubMed
23376840Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23376840PubMed
21063479Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population.Hepatol Int2010https://conductscience.org/library/papers/21063479PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8995940

GET https://conductscience.org/api/papers/v1/8995940/cited_by?page=2